当科における口腔癌の治療成績―24年間の検討―

DOI Web Site Web Site 参考文献9件
  • 野呂 恵起
    大阪医科薬科大学耳鼻咽喉科・頭頸部外科学教室
  • 河田 了
    大阪医科薬科大学耳鼻咽喉科・頭頸部外科学教室
  • 寺田 哲也
    大阪医科薬科大学耳鼻咽喉科・頭頸部外科学教室
  • 東野 正明
    大阪医科薬科大学耳鼻咽喉科・頭頸部外科学教室
  • 粟飯原 輝人
    大阪医科薬科大学耳鼻咽喉科・頭頸部外科学教室
  • 神人 彪
    大阪医科薬科大学耳鼻咽喉科・頭頸部外科学教室
  • 木下 一太
    大阪医科薬科大学耳鼻咽喉科・頭頸部外科学教室

書誌事項

タイトル別名
  • Clinical Outcomes of Treatment for Oral Cancer at Osaka Medical and Pharmaceutical University: A 24-year Experience
  • トウ カ ニ オケル コウクウ ガン ノ チリョウ セイセキ : 24ネンカン ノ ケントウ

この論文をさがす

説明

<p>We retrospectively analyzed the treatment results in 543 oral cancer patients who were admitted to our department between September 1999 and March 2023. The tongue was the most common primary subsite, followed by the gingiva and oral floor. Among the total of 543 cases of oral cancer, there were 132 clinical node-positive cases (24%). The overall 5-year disease-specific survival (DSS) rate was 71.8%, and the 5-year DSS rates in the stage I, II, III, and IV oral cancer cases were 91.5%, 81.2%, 62.1%, and 48.5% respectively. The 5-year DSS rates in the stage I, II, III, and IV tongue cancer cases were 91.4%, 80.6%, 59.5%, and 44.9%, respectively. The new N classification was more reliably associated with the survival as compared with previous N classifications in the tongue carcinoma cases. Among the 184 cases with T2 oral cancer, 77 (42%) were node-positive. An advanced T stage and a positive neck nodal status were significantly associated with poorer 5-year DSS rates.</p>

収録刊行物

参考文献 (9)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ